pyrazines has been researched along with mk-1775 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasvold, G; Hauge, S; Joel, M; Juzenas, P; Naucke, C; Rødland, GE; Stokke, T; Syljuåsen, RG | 1 |
| Bueno, R; Carrasco, RD; Case, AE; Frank, DA; Garg, S; Gokhale, PC; Griffin, JD; Hung, YP; Knott, A; Kulkarni, P; Lapidot, M; Meng, C; Ni, W; Podar, K; Pozhitkov, A; Saladi, SV; Salgia, R; Sattler, M; Sharma, S; Walker, SR; Weisberg, EL | 1 |
2 other study(ies) available for pyrazines and mk-1775
| Article | Year |
|---|---|
Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading.
Topics: A549 Cells; Cell Cycle Proteins; Cell Line, Tumor; Checkpoint Kinase 1; Cyclin-Dependent Kinases; DNA Damage; DNA Replication; Drug Synergism; Flow Cytometry; Humans; Nuclear Proteins; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazines; Pyrazoles; Pyrimidines; Pyrimidinones; S Phase; Thiophenes; Urea | 2017 |
Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM).
Topics: Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Jumonji Domain-Containing Histone Demethylases; Mesothelioma, Malignant; Mice; Pyrazines; Pyrazoles; Pyrimidinones; Sulfonamides; Up-Regulation; Xenograft Model Antitumor Assays | 2021 |